Table 1.
Medications for treating dementia with Lewy bodies
| Core feature | Drug class | Drug (generic) | Sample size (n) | References |
|---|---|---|---|---|
| Dementia | Cholinesterase inhibitor | Rivastigmine | 120 | [30] |
| Galantamine | 50 | [31] | ||
| Donepezil | 140 | [33] | ||
| NMDA receptor antagonist | Memantine | 72 | [36] | |
| 199 | [37] | |||
| Hallucinations | Cholinesterase inhibitor | Rivastigmine | 120 | [30] |
| Galantamine | 50 | [31] | ||
| Donepezil | 140 | [33] | ||
| Atypical antipsychotic (dopamine antagonist) | Quetiapine | 40 | [40] | |
| Novel antipsychotic (5-HT2A inverse agonist) | Pimavanserin | – | [41] | |
| Parkinsonism | Dopamine precursor | Levodopa | – | [5, 38, 42] |
| Anticonvulsant | Zonisamide | 158 | [43] | |
| Fluctuations and agitation | Atypical antipsychotic (dopamine antagonist) | Quetiapine | – | [38, 40] |
| Anticonvulsant | Valproic acid, divalproex | – | [50, 52, 53] | |
| REM sleep behavior disorder | Benzodiazepine | Clonazepam | – | [54, 59] |
| Hormone | Melatonin | 110 | [60] | |
| 14 | [61] |
5-HT 5-hydroxytryptophan, NMDA N-methyl-d-aspartate, REM rapid eye movement